Image of Mercedes Corina Becerra

Mercedes Becerra, Sc.D.

Jeffrey Cheah Professor of Global Health and Social Medicine, Harvard Medical School
Faculty Dean of Adams House, Faculty of Arts & Sciences

Mercedes C. Becerra, ScD, is the Jeffrey Cheah Professor of Global Health and Social Medicine at Harvard Medical School. She is also the Faculty Dean of Adams House at Harvard College.  Professor Becerra completed the AB degree at Harvard College in 1991 (History), followed by the MSc (Population and International Health) in 1993 and the DSc (Epidemiology) in 1999, both at the Harvard School of Public Health. 

For more than 25 years, Professor Becerra has conducted research focused on improving the treatment of drug-resistant tuberculosis (TB), strategies to estimate and detect TB in children, and strategies to treat and prevent TB in families exposed at home to this airborne infection. She sustains long-term collaborative partnerships with three international health delivery organizations: Partners In Health, IRD Global, and Advance Access & Delivery. Professor Becerra is co-founder of the Sentinel Project on Pediatric Drug-Resistant Tuberculosis— a network of clinicians, investigators, and advocates who collaborate to share evidence and resources that can increase children’s access to prompt and effective treatment.  Professor Becerra is also a co-founder of the Zero TB Initiative— a global consortium of local coalitions working to drive down TB rates, one community at a time.

Dr. Becerra's research focuses on the treatment and epidemiology of tuberculosis. She studies the burden of tuberculosis in the child and adult household contacts of tuberculosis patients. She also studies strategies to improve tuberculosis screening and treatment in children and high-risk households.

Complete list of Dr. Mercedes Becerra's publications on MyBibiliography.

Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.
Authors: Authors: Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC.
PLoS One
View full abstract on Pubmed
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.
Authors: Authors: Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC.
PLoS One
View full abstract on Pubmed
High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting.
Authors: Authors: Satti H, McLaughlin MM, Seung KJ, Becerra MC, Keshavjee S.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Adaptation of a web-based, open source electronic medical record system platform to support a large study of tuberculosis epidemiology.
Authors: Authors: Fraser HS, Thomas D, Tomaylla J, Garcia N, Lecca L, Murray M, Becerra MC.
BMC Med Inform Decis Mak
View full abstract on Pubmed
Impact of rapid drug susceptibility testing for tuberculosis: program experience in Lima, Peru.
Authors: Authors: Shin SS, Asencios L, Yagui M, Yale G, Suárez C, Bayona J, Bonilla C, Jave O, Contreras CC, Atwood S, Blaya JA, Ershova J, Cegielski JP.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Authors: Authors: Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P.
Lancet
View full abstract on Pubmed
Community-based rapid oral human immunodeficiency virus testing for tuberculosis patients in Lima, Peru.
Authors: Authors: Nelson AK, Caldas A, Sebastian JL, Muñoz M, Bonilla C, Yamanija J, Jave O, Magan C, Saldivar J, Espiritu B, Rosell G, Bayona J, Shin S.
Am J Trop Med Hyg
View full abstract on Pubmed
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects.
Authors: Authors: Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP.
Tuberculosis (Edinb)
View full abstract on Pubmed
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects.
Authors: Authors: Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP.
Tuberculosis (Edinb)
View full abstract on Pubmed
Engaging the private sector to increase tuberculosis case detection: an impact evaluation study.
Authors: Authors: Khan AJ, Khowaja S, Khan FS, Qazi F, Lotia I, Habib A, Mohammed S, Khan U, Amanullah F, Hussain H, Becerra MC, Creswell J, Keshavjee S.
Lancet Infect Dis
View full abstract on Pubmed